# Cross Linking for Treatment of Corneal Infection

> **NCT00912509** · NA · TERMINATED · sponsor: **Price Vision Group** · enrollment: 30 (actual)

## Conditions studied

- Infectious Keratitis

## Interventions

- **DRUG:** riboflavin
- **DEVICE:** UVX Light

## Key facts

- **NCT ID:** NCT00912509
- **Lead sponsor:** Price Vision Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** insufficient efficacy
- **Last updated:** 2017-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00912509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00912509, "Cross Linking for Treatment of Corneal Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00912509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*